When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNCA - Genocea jumps on positive data on neoantigen cell therapy
Genocea Biosciences Inc.
Thinly traded nano cap Genocea Biosciences (NASDAQ:GNCA) is up 16% premarket on average volume on the heels of a key opinion leader (KOL) symposium yesterday focused on GEN-011, its neoantigen cell therapy that, it says, improves on the limitations of tumor-infiltrating lymphocyte (TIL) therapy.
More news on: Genocea Biosciences, Inc., Healthcare stocks news, Stocks on the move,